‘Silent’ heart attack boosts dementia risk

Catch up with NBC News Clone on today's hot topic: Wbna24859342 - Breaking News | NBC News Clone. Our editorial team reformatted this story for clarity and speed.

Men who are found to have had an unrecognized or "silent" heart attack are at increased risk of developing dementia or small lesions in the brain that can affect cognition, a study finds.

Men who are found to have had an unrecognized or "silent" heart attack are at increased risk of developing dementia or small lesions in the brain that can affect cognition, Dutch researchers report.

Dr. Monique M. B. Breteler told Reuters Health that her group had previously found that men, but not women, with a silent heart attack are more likely to have a stroke than men who had a recognized heart attack or those who had not had any heart attack.

To examine whether this might also be the case for dementia and so-called cerebral small vessel disease, Breteler of Erasmus University, Rotterdam, and her colleagues examined data for more than 6,300 participants in a population-based study.

At the start of the study, from 1990 to 1993, the subjects were classified as having a recognized heart attack, not having a heart attack, or having had an unrecognized heart attack based on EKG tracings. They were followed for the occurrence of dementia, of which there were 613 cases by 2005.

The team also examined data for 436 subjects without dementia who underwent MRI brain scans.

Compared to men who had not had a heart attack, men with an unrecognized heart attack were more than twice as likely to develop dementia. They also had more brain lesions and showed signs of cerebral blood vessel blockages more often on MRI, the team reports in the American Heart Association's journal Stroke.

There were no associations between dementia risk and unrecognized heart attacks in women, or among men and women with recognized heart attacks.

The researchers conclude that using an EKG to screen men to see if they've had an unrecognized heart attack "might identify those at an increased risk of various adverse outcomes." They might then benefit from subsequent preventive therapy.

"However," Breteler pointed out, "before such screening can be initiated, it should first be evaluated for efficacy and cost-effectiveness in adequately designed randomized controlled studies."

×
AdBlock Detected!
Please disable it to support our content.

Related Articles

Donald Trump Presidency Updates - Politics and Government | NBC News Clone | Inflation Rates 2025 Analysis - Business and Economy | NBC News Clone | Latest Vaccine Developments - Health and Medicine | NBC News Clone | Ukraine Russia Conflict Updates - World News | NBC News Clone | Openai Chatgpt News - Technology and Innovation | NBC News Clone | 2024 Paris Games Highlights - Sports and Recreation | NBC News Clone | Extreme Weather Events - Weather and Climate | NBC News Clone | Hollywood Updates - Entertainment and Celebrity | NBC News Clone | Government Transparency - Investigations and Analysis | NBC News Clone | Community Stories - Local News and Communities | NBC News Clone